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Abstract
Background: The 'hygiene hypothesis' suggests that early exposure to microbes can be protective
against atopic disease. The intestinal microbial flora could operate as an important postnatal
regulator of the Th1/Th2 balance. The aim of the study was to investigate the association between
early intestinal colonisation and the development of asthma in the first 3 years of life.
Methods: In a prospective birth cohort, 117 children were classified according to the Asthma
Predictive Index. A positive index included wheezing during the first three years of life combined
with eczema in the child in the first years of life or with a parental history of asthma. A faecal sample
was taken at the age of 3 weeks and cultured on selective media.
Results: Asthma Predictive Index was positive in 26/117 (22%) of the children. The prevalence of
colonisation with Bacteroides fragilis was higher at 3 weeks in index+ compared to index- children
(64% vs. 34% p < 0,05). Bacteroides fragilis and Total Anaerobes counts at 3 weeks were significantly
higher in children with a positive index as compared with those without. After adjusting for
confounders a positive association was found between Bacteroides fragilis colonisation and Asthma
Predictive Index (odds ratio: 4,4; confidence interval: 1,7 – 11,8).
Conclusion: Bacteroides fragilis colonisation at age 3 weeks is an early indicator of possible asthma
later in life. This study could provide the means for more accurate targeting of treatment and
prevention and thus more effective and better controlled modulation of the microbial milieu.
Background
Wheezing at an early age is a major health problem: at
least 1 episode of wheezing occurs in 50% of children
under 5 years [1]. Wheezing children are a heterogeneous
group and many patterns of wheezing disorders seem to
exist: some children wheeze with viral infections only dur-
ing the first years of life and do not subsequently develop
asthma and some may have early childhood asthma.
Studies of the natural history of the disease have demon-
strated that in most cases of persistent asthma the initial
asthma-like symptoms occur during the first several years
of life.
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The mechanism by which predisposing and protective risk
factors interact to induce asthma remains unclear. The
'hygiene hypothesis' suggests that early exposure to
microbes and allergens can be protective: a western life-
style causes the immune system to mature in a way that
predisposes to asthma in genetically prone individuals
[2]. The intestinal microbial flora could operate as an
important postnatal regulator of the Th1 and Th2 balance.
The normal intestinal flora is essential in the maintenance
of oral immune tolerance by inhibition of potential lym-
phocyte reactivity [3]. Specific bacterial surface determi-
nants and DNA sequences induce production of Th1
cytokines through NF-kB and STAT signaling pathways in
human macrophages. Lactobacillus rhamnosus "GG" has
been shown to induce this response [4]. The gut flora of
healthy infants shows differences with allergic infants.
More  Clostridia  and fewer Bifidobacteria  were found in
infants at 3 weeks and 3 months of age who would later
develop atopy [5]. In allergic infants (2–7 months of age)
more Bifidobacterium adolescentis and longum were found
as compared to healthy infants showing more Bifidobacte-
rium bifidum [6].
Large scale epidemiological studies studying the micro-
bial gut flora in young children from the general popula-
tion are lacking.
The Asthma and Allergy study evaluates the intestinal
flora in a prospective birth cohort recruited from the gen-
eral population and followed up to the age of 3 years. A
total of 158 children were included, the largest cohort ever
that studied the relation between microbial gut flora and
asthma. A positive association was found between early
Bacteroides fragilis colonisation and a positive Asthma Pre-
dictive Index, a clinical predictor of school age asthma.
Methods
The Asthma and Allergy study is a prospective birth cohort
and part of the Environmental Health action of the Flem-
ish Ministry of Health and Environment. Children (n =
158) were recruited through maternity clinics in Flanders.
Selection criteria for enrolment in the study were vaginal
delivery at term and uncomplicated perinatal period.
Questionnaires were collected with data on the parents,
including demography, smoking and asthma. Data of the
child on demography, respiratory symptoms and risk fac-
tors for asthma were collected by postal questionnaires
send every 6 months starting at the age of 3 weeks until
the age of 36 months. The question on the presence of
wheezing referred to the period between two question-
naires, e.g. the presence of wheezing in the questionnaire
at 6 months referred to the time period between 3 weeks
and 6 months. The study protocol was approved by the
medical ethics committees of the participating institutes.
All parents gave written informed consent.
Symptoms of wheeze were assessed by International
Study of Asthma and Allergies in Childhood core ques-
tions [7]. Information about doctor's diagnosed parental
asthma was collected by the following question: "Did a
doctor ever diagnose asthma?". Based on the longitudinal
questionnaire data on wheeze symptoms in the first 3
years of life, children were classified according to the
'loose' Asthma Predictive Index (API) into an API positive
and an API negative group. According to the 'loose' index
a positive API included wheezing during the first three
years of life and eczema or parental history of asthma [8].
Approximately 2 g of stools was collected into a sterile
recipient by the parents at 3 weeks of age. The sample was
sent to the laboratory under anaerobic conditions where
it was stored immediately at -70°C until analysis. A total
anaerobe count was obtained by quantitative plating of a
saline suspension of faeces on Columbia blood agar after
4 days of anaerobic incubation at 37°C. The saline sus-
pension of faeces consisted of 1 g of wet faeces diluted in
10 ml of sterile saline solution, homogenized using a
stomacher. Selective media were used to study the bacte-
rial subpopulations [9]. Bacteroides fragilis group (subse-
quently called Bacteroides fragilis) was determined
quantitatively on Bacteroides Bile Esculin agar (BBE) (Bec-
ton-Dickinson, Belgium); only black pigmented colonies
obtained after 4 days of anaerobic incubation at 37°C
were considered [10]. Bifidobacterium was determined on
mupirocin (100 μg/ml) trypticase-phytone-yeast agar;
only colonies smaller than 0.7 mm obtained after 4 days
of anaerobic incubation at 37°C were considered [11].
Lactobacilus  was cultured on LAMVAB medium [12].
Green and white colonies obtained after 4 days of anaero-
bic incubation were considered. Clostridium counts were
obtained after pretreatment of the faecal sample in 80%
ethanol for 15 min. and subsequent culture on Columbia
blood agar after 4 days of anaerobic incubation at 37°C.
Because bacterial counts followed a right-skewed distribu-
tion, data were log10-transformed. Chi-square was used
to compare characteristics of API positive versus API neg-
ative subjects. The not normally distributed log trans-
formed counts were compared using non-parametric tests
(Friedman and Mann-Whitney rank sum test where
appropriate using SPSS software version 12.0). Median
and range of the bacterial counts were reported as log 10
CFU/g faeces. The detection level was ≥ 3 log CFU/g.
Bacteroides fragilis group colonisation was estimated by
multiple logistic regression analysis, with colonisation as
the independent variable and asthma predictive index as
dependent variables. We applied multiple imputation to
investigate the stability of the results due to missing data.
For multiple imputations, each missing value was
replaced with a set of numbers (Markov chain Monte
Carlo method) [13]. We analysed the results of eachBMC Pulmonary Medicine 2008, 8:19 http://www.biomedcentral.com/1471-2466/8/19
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imputation as complete data sets and we combined the
results of these analyses.
Results
Description of the study population
Of the 158 children recruited in this study, 54% were
boys. Maternal or paternal asthma was present in 8% and
5% of the children, respectively. Several children were lost
for follow-up at the end of the 3 year study period. As a
result, API at age 3 years could not be determined in 41 of
the 158 children due to missing data on wheezing (n =
30) or on eczema (n = 9) of the child in the 6 monthly
questionnaires or on parental asthma (n = 5). There were
no differences in the percentage of children with wheeze
at any age, parental asthma, and eczema at any age or gen-
der of the infant between children who could or could not
be categorized according to API. API was positive in 26/
117 (22%) of the children. Table 1 describes the charac-
teristics of the API+ and API- children.
Faecal microorganisms in the study population
A total of 149 faecal samples were collected, which is a
response rate of 94%. The prevalence of colonisation with
Bacteroides fragilis was higher at 3 weeks in API+ children
than in API- children (64% vs. 34%, p < 0. 05, table 2).
Bacteroides fragilis and Total Anaerobes counts at 3 weeks,
expressed in log CFU/g, were significantly higher in chil-
dren with positive API as compared with those without
(table 3).
Logistic regression analysis
There were no major differences between the results of the
crude and adjusted analyses for Bacteroides fragilis coloni-
sation. Further adjustment for exclusive breast feeding,
maternal smoking during pregnancy, infant use of antibi-
otics at age of 3 weeks, parental socio-economic status and
gender did not alter the results of the analysis (table 4).
Multiple imputation analysis
Colonisation with Bacteroides fragilis was still significantly
associated with API both univariately (odds ratio = 3.57;
p = 0.002) and in a multiple model controlling for the fac-
tors in Table 4 (odds ratio = 2.75; p = 0.01).
Discussion
This is the first prospective cohort study that links gut flora
to API (a clinically relevant risk factor for developing
asthma) at the age of 3 years. It was demonstrated that dif-
ferences in gut flora precede the development of asthma:
early colonisation with Bacteroides fragilis was more often
found in recurrent wheezing children at risk of persistent
asthma at school age. Differences in feeding or use of anti-
biotics cannot explain the findings.
Between 25 and 50% of children suffer from one or more
wheezing episodes below the age of 6. However, wheezing
illness below the age of 6 years is not a single disease, but
comprises several distinct disorders. Asthma phenotypes
have been identified in epidemiologic trials, each with
their own risk factors and different outcome. Overall, 30–
40% of the children presenting with wheezing below the
age of 3, will wheeze later in life. Decreased airway calibre
could be an important factor in pathophysiology, explain-
ing the transient nature of wheeze in many children. The
diagnosis is not straightforward since no simple clinical
tools are available to discriminate children prone to
develop persistent asthma from those who will not. The
'Asthma Prediction Index' has been associated with an
increased risk for asthma at school age [8]. This index was
chosen as outcome parameter for the study since it is at
present the best tool for prediction of asthma at school
age. A 'stringent' index that required subjects to have
wheezed more frequently in early life combined with risk
factors for asthma had an acceptable positive predictive
value (e.g. at age 13: 51%) and a very high specificity
(97%), but its sensitivity was quite low (15%). Con-
versely, a more 'loose' index, which only required infre-
quent wheezing episodes plus the same combination of
other risk factors included in the 'stringent' index had a
much higher sensitivity (39%) but lower specificity (82%)
and positive predictive values (32%). The negative predic-
tive value at all ages was very high for both indices, sug-
gesting that the great majority of children who did not
develop asthma during the school years had a negative
predicted index during the first years of life. Because the
Asthma Predictive Index is only an approximation to pre-
dict which children will subsequently develop persistent
Table 1: Characteristics for API+ versus API- children at age 3 years.
Factor API + API- P value
Gender (Male) 18/26 (69%) 48/91 (53%) NS
Exclusive breast feeding ≤ 3 weeks 20/26 (77%) 63/91 (69%) NS
Antibiotic use ≤ 3 weeks 0/26 (0%) 2/90 (2%) NS
Wheeze ever 26/26 (100%) 41/91 (45%) < 0,0001
Eczema ever 20/26 (77%) 9/90 (10%) < 0,0001
Maternal asthma 6/25 (24%) 3/90 (3%) 0,003
Paternal asthma 6/23 (26%) 1/88 (1%) < 0,0001
Maternal smoking during pregnancy 2/26 (8%) 5/89 (6%) NSBMC Pulmonary Medicine 2008, 8:19 http://www.biomedcentral.com/1471-2466/8/19
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asthma, further follow-up at school age is required to def-
initely determine the relation between early Bacteroides
fragilis colonisation and asthma.
At birth the gastrointestinal tract is sterile and becomes
colonised during the first months of life until an adult-
pattern of stable gut flora is established. The gut associ-
ated lymphoid tissue (GALT) matures during the first year
of life, which requires microbial stimulation. Without
such stimuli inappropriate GALT maturation results in
defects in the oral tolerance [14]. Germ-free mice could
develop oral tolerance if the gut flora was reconstituted
with Bifidobacterium not later than during the neonatal
period.
Improved hygiene has altered microbial exposure early in
life, which has been suggested as a cause for the rising
prevalence of atopic diseases [15]. Epidemiologic studies
have shown that in particular food-borne and orofecal
infections might be essential in the prevention of atopy
[16]. It would seem unlikely however, that a stimulus that
is potentially harmful to the host should be necessary for
the postnatal maturation of a balanced immune system.
Since the host's major and primary microbial stimulation
occurs along with the establishment of the gut microflora,
it has been suggested that exposure to commensal micro-
flora or specific strains may represent a key modulator of
the immune system against atopic diseases [17].
Our study shows that early colonisation with Bacteroides
fragilis at age 3 weeks was associated with a positive API at
age 3 years. No studies have looked prospectively at the
relationship between early colonisation and development
of asthma and particularly at API as outcome parameter.
In a cross sectional study differences in gut flora have been
observed between allergic and non-allergic infants [18]. In
62 Swedish and Estonian children counts of Staphylococcus
aureus were higher and the proportion of Bacteroides was
lower in the allergic children compared to the non-allergic
children at age 2 years [18]. In a later prospective study
Björksten followed 24 Estonian and 20 Swedish children
from birth till 2 years of age. Infants who developed
allergy, as demonstrated by skin prick test, were less often
colonized with Enterococcus during the first month of life
and had higher count of Clostridium at 3 months [19]. The
prevalence of Staphylococcus aureus was also higher at 6
months, whereas the Bacteroides counts were lower at 12
months [19]. In a prospective study during the first 6
months of life Kalliomaki showed that differences in neo-
natal gut flora preceded the development of a positive
skin prick test: allergic infants had more Clostridium and
tended to have fewer Bifidobacterium at age 3 weeks in
their stools than non allergic infants [5]. The fact that
other authors did find differences in other intestinal bac-
terial species besides Bacteroides might be explained by the
fact that timing of the sampling was different (older chil-
dren), patient selection was different (allergic, skin test
positive patients) or because the culture media used were
less selective. Especially for Bifidobacterium (MTPY versus
NPNL or RB medium), Bacteroides (BBE versus Schaedler
medium including vancomycin and nalidixic acid) and
Lactobacillus (LAMVAB versus MRS or Rogosa medium) we
used more selective media than previous authors.
In a mouse model Mazmanian et al. showed that Polysac-
charide A (PSA), a bacterial polysaccharide, stimulates the
expansion of CD4+ T cells and Th1 cytokine production
[20]. This is not in agreement with the findings in our
study. Several factors can explain this difference. First, a
dose effect might be involved: we observed a median fae-
cal Bacteroides count in infants of 3.5 log CFU/g (range 0–
8.2) in contrast to the much higher counts during the
monocolonisation of the germfree mice (> 10 log CFU/g).
Similarly to endotoxin which has been shown to exert a
Th1 response at high dose and a Th2 response at low dose,
the cytokine response to PSA might be dose dependent.
Second, PSA is only one of 8 capsular polysaccharides
known to be produced by Bacteroides fragilis and regulated
by DNA inversions. The immune response to these other
7 polysaccharides remains unknown. Moreover, Coyne et
al. showed that fucosylation of these polysaccharides by
the host results in rendering these bacteria immunological
inert [21]. The fucosylation by the host was shown to be
important in the gut colonisation ability of Bacteroides fra-
Table 2: Prevalence of faecal microorganisms at 3 weeks of age
Bacteria API- (n = 91) API+ (n = 26)





Total Anaerobes 99 100
Prevalence (%) of microorganisms for API+ versus API- (n = number 
of infants): *: p < 0.05
Table 3: Median counts of faecal microorganisms (log CFU/g) 
(range) in API- and API+ children at the age of 3 weeks 
Bacteria API- (n = 91) API+ (n = 26)
Bacteroides fragilis 1,8* (0–8,7) 3,5* (0–8,2)
Bifidobacterium 5,6 (0–9,1) 5,8 (0–8,7)
Lactobacillus 2,1 (0–8,6) 1,7 (0–8,5)
Clostridium 2,7 (0–6,2) 2,8 (0–6,1)
Staphylococcus 4,4 (0–8,6) 3,9 (0–8,1)
Total Anaerobes 7,3* (0–9,1) 7,9* (6,3–8,9)
Counts of faecal microorganisms for API+ versus API- (n = number of 
infants): *:p < 0.05.BMC Pulmonary Medicine 2008, 8:19 http://www.biomedcentral.com/1471-2466/8/19
Page 5 of 6
(page number not for citation purposes)
gilis. We believe that intestinal Bacteroides species might be
able to induce a Th2 cytokine response through binding
of a TLR2 (Toll-like receptor) present on intestinal den-
dritic cells. Netea et al. showed that Bacteroides species
stimulate cytokine release through TLR2-dependent (not
TLR4) mechanisms [22]. TLR2 agonists induce a Th2
response by suppressing IL-12 production [23].
To our knowledge there are no data linking Bacteroides
and asthma. However, two reports found an association
between Bacteroides and IgE or IgG immune response in
allergic children. Fukuda studied 867 junior high school
children and administered a questionnaire concerning
allergic symptoms. A higher IgG titer to Bacteroides vulgaris
was found in the children with allergic symptoms [24]. In
infants intolerant to extensively hydrolysed whey formula
serum total IgE concentration was shown to correlate with
faecal Bacteroides counts at age 4–6 months and bifidobac-
terial supplementation prevented increases in Bacteroides
during weaning [25]. In non-allergic Estonian children
the faecal counts of Bacteroides at age 5 years correlated
positively with the serum IgE concentration [26]. One
report in a mouse model supports the findings of our
study. In BALB/c mice at 3 weeks of age a kanamycine
induced elevation of serum IgE levels was enhanced by the
inoculation with Bacteroides vulgatus [27]. Finally, a study
in adults with pollen allergy showed an increased ratio of
faecal counts of Bacteroides fragilis to Bifidobacterium dur-
ing pollen season. This rise was prevented by bifidobacte-
rial supplementation. In vitro, using peripheral blood
mononuclear cells of these patients they also demon-
strated that Bacteroides fragilis strains induced more Th2
cytokines but fewer Th1 cytokines compared with Bifido-
bacterium strains [28]. A limitation of the present study is
the fact that no stool sample of the mother was included,
so we cannot make any statement on the origin of the
Bacteroides fragilis strains recovered in these infants.
Finally, as in every longitudinal study, missing data is a
hindrance. However, after multiple imputation, the inter-
pretation of the original results has been confirmed.
Conclusion
Modulation of the composition of the gut flora could con-
tribute to alleviation of the symptoms of asthma. The
desirable modification was identified as restraining of the
Bacteroides fragilis flora. Detailed analyses of the gut flora
of wheezing infants at different ages and at the species
level are needed for a better understanding of the signifi-
cance of the intestinal flora associated abnormalities in
asthma. Such studies should also provide the means for
more accurate targeting of treatment and prevention and
thus more effective and better controlled modulation of
the microbial milieu.
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